Kinetic of Cytokines Decrease and Hodgkin Lymphoma Prognostic
Condition(s):Hodgkin’s DiseaseLast Updated:July 21, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Hodgkin’s DiseaseLast Updated:July 21, 2017Completed
Condition(s):Hodgkin Lymphoma; Refractory Hodgkin LymphomaLast Updated:July 7, 2021Completed
Condition(s):Diffuse Large B-cell-lymphomaLast Updated:January 2, 2024Not yet recruiting
Condition(s):Recurrent Classic Hodgkin Lymphoma; Refractory Classic Hodgkin LymphomaLast Updated:April 20, 2020Completed
Condition(s):Intestinal GVHD; Steroid Refractory GVHDLast Updated:October 11, 2023Recruiting
Condition(s):Adult Lymphocyte Depletion Hodgkin Lymphoma; Adult Lymphocyte Predominant Hodgkin Lymphoma; Adult Mixed Cellularity Hodgkin Lymphoma; Adult Nodular Sclerosis Hodgkin Lymphoma; Recurrent Adult Hodgkin LymphomaLast Updated:February 23, 2015Completed
Condition(s):Graft-vs-Host Disease; GVHDLast Updated:July 26, 2018Terminated
Condition(s):Anaplastic Large Cell Lymphoma; Recurrent Childhood Anaplastic Large Cell LymphomaLast Updated:March 14, 2018Terminated
Condition(s):Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-CellLast Updated:November 28, 2016Completed
Condition(s):Atopic DermatitisLast Updated:February 12, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.